Acelity V.A.C.ULTA, Safety Information And Application Instructions

Page: 5 / 396

5
TRANSITIONING V.A.C.® THERAPY INTO HOME CARE
The V.A.C.Ulta™ Therapy System is not intended for home use. If there is a need to continue
V.A.C.® Therapy when a patient transitions home, consider using other KCI Therapy Systems
approved for the post-acute care environment. Refer to the safety information included with
those devices for important information.
V.A.C.ULTA™ THERAPY SYSTEM CONTRAINDICATIONS
•
Do not place foam dressings of the V�A�C�Ulta™ Therapy System (including both V�A�C�® Therapy and
V�A�C� VeraFlo™ Therapy Dressings) directly in contact with exposed blood vessels, anastomotic sites,
organs, or nerves�
NOTE:
Refer to
Warnings
section for additional information concerning
Bleeding
.
•
V�A�C�® Therapy and V�A�C� VeraFlo™ Therapy are contraindicated for patients with:
•
Malignancy in the wound
•
Untreated osteomyelitis
NOTE: Refer to Warnings section for Osteomyelitis information.
•
Non-enteric and unexplored fistulas
•
Necrotic tissue with eschar present
NOTE: After debridement of necrotic tissue and complete removal of eschar, V.A.C.® Therapy may
be used.
•
Sensitivity to silver (V�A�C� GranuFoam Silver® Dressing only)
ADDITIONAL CONTRAINDICATIONS SPECIFIC TO V.A.C. VERAFLO™
THERAPY
•
Do not use V�A�C�® Dressings with Octenisept®*, hydrogen peroxide or solutions that
are alcohol-based or contain alcohol�
•
Do not deliver fluids to the thoracic or abdominal cavity due to the potential risk to
alter core body temperature and the potential for fluid retention within the cavity�
•
Do not use V�A�C� VeraFlo™ Therapy unless the wound has been thoroughly explored
due to the potential for inadvertent instillation of topical wound solutions to
adjacent body cavities�
* Not available in the United States� Brand name referenced is not a trademark of KCI, its
affiliates, or licensors�